Idorsia’s Insomnia Drug Daridorexant Among 14 Hopefuls For EU Verdict
Immunocore’s Tebentafusp Could Also Get A Marketing Recommendation
The European Medicines Agency will likely decide this week whether to recommend for pan-EU approval new treatments for insomnia, uveal melanoma, migraine and advanced prostate cancer.
